VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial
BLOOD (2016)
期刊
BLOOD
卷 127, 期 21, 页码 2569-2574出版社
AMER SOC HEMATOLOGY
关键词
类别
作者
我是这篇论文的作者
推荐
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma
Tomonori Nakazato, Masao Hagihara, Naohi Sahara, Yotaro Tamai, Ryuji Ishii, Shigehisa Tamaki, Atsushi Wake, Kenji Tajika, Rika Sakai, Takeshi Kobayashi, Jian Hua, Morihiro Inoue, Yoshinobu Aisa, Shin Fujisawa, Koji Miyazaki, Seiji Irie, Eri Tanaka, Masaaki Higashihara
ANNALS OF HEMATOLOGY (2021)
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
Susanne Ghandili, Dzenefa Alihodzic, Christian Wiessner, Carsten Bokemeyer, Katja Weisel, Lisa B. Leypoldt
ANNALS OF HEMATOLOGY (2023)
The association of prior paracetamol intake with outcome of very old intensive care patients with COVID-19: results from an international prospective multicentre trial
Philipp Heinrich Baldia, Bernhard Wernly, Hans Flaatten, Jesper Fjolner, Antonio Artigas, Bernardo Bollen Pinto, Joerg Schefold, Malte Kelm, Michael Beil, Raphael Romano Bruno, Stephan Binneboessel, Georg Wolff, Ralf Erkens, Sviri Sigal, Peter Vernon van Heerden, Wojciech Szczeklik, Muhammed Elhadi, Michael Joannidis, Sandra Oeyen, Brian Marsh, Finn Andersen, Rui Moreno, Susannah Leaver, Dylan De Lange, Bertrand Guidet, Christian Jung
BMC GERIATRICS (2022)
Nocturnal dexmedetomidine alleviates post-intensive care syndrome following cardiac surgery: a prospective randomized controlled clinical trial
Chun-Hui Dong, Chao-Nan Gao, Xiao-Hua An, Na Li, Le Yang, De-Cai Li, Qi Tan
BMC MEDICINE (2021)
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial
Timo Rath, Raja Atreya, Julia Bodenschatz, Wolfgang Uter, Carol E. Geppert, Francesco Vitali, Sarah Fischer, Maximilian J. Waldner, Jean-Frederic Colombel, Arndt Hartmann, Markus F. Neurath
GASTROENTEROLOGY (2023)
Not using a tourniquet is superior to tourniquet use for high tibial osteotomy: a prospective, randomised controlled trial
Songlin Li, Xiangshuai Zhang, Mingxing Liu, Qunshan Lu, Yang Yu, Zhuang Miao, Desu Luo, Kaifei Han, Lei Li, Wenwei Qian, Peilai Liu
INTERNATIONAL ORTHOPAEDICS (2022)
Focused, low tube potential, coronary calcium assessment prior to coronary CT angiography: A prospective, randomized clinical trial
Hampton A. Crimm, Nicole M. Fergestrom, Cicely Dye, Cynthia Philip, Binh T. Nguyen, Todd C. Villines
JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY (2021)
Central Venous Catheter Cannulation in Pediatric Anesthesia and Intensive Care: A Prospective Observational Trial
Vaclav Vafek, Tamara Skrisovska, Martina Kosinova, Eva Klabusayova, Tereza Musilova, Tereza Kramplova, Jana Djakow, Jozef Klucka, Jiri Kalina, Petr Stourac
CHILDREN-BASEL (2022)
Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications
Suzanne R. Sharpton, Norah A. Terrault, Mehdi M. Tavakol, Andrew M. Posselt
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study
Magdalena Stepien, Pekka Keski-Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte-Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjonneland, Agnetha Linn Rostgaard-Hansen, Christina C. Dahm, Kim Overvad, Marie-Christine Boutron-Ruault, Francesca Romana Mancini, Yahya Mahannat-Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kuehn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C. H. Vermeulen, Hendrik Bastiaan Bueno-de-Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramon Quiros, Eva Ardanaz, Olatz Mokoroa, Nuria Sala, Maria-Jose Sanchez, Jose Maria Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjoberg, Julie A. Schmidt, Nick Wareham, Kay-Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert, Mazda Jenab
INTERNATIONAL JOURNAL OF CANCER (2021)
Bridging Allograft Reconstruction Is Superior to Maximal Repair for the Treatment of Chronic, Massive Rotator Cuff Tears Results of a Prospective, Randomized Controlled Trial
Ivan Wong, Sara Sparavalo, John-Paul King, Catherine M. Coady
AMERICAN JOURNAL OF SPORTS MEDICINE (2021)
Is the Anterior Injection Approach Without Ultrasound Guidance Superior to the Posterior Approach for Adhesive Capsulitis of the Shoulder? A Sequential, Prospective Trial
Zeger Rijs, Pieter C. J. de Groot, Eline W. Zwitser, Cornelis P. J. Visser
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2021)
Does implant removal of superior clavicle plate osteosynthesis affect the functional outcome: a prospective trial
Markus Wurm, Marc Beirer, Michael Zyskowski, Christopher Volk, Arthur Schwarz, Peter Biberthaler, Chlodwig Kirchhoff, Moritz Cronlein
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2022)
Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study
Susan Mawson, Carol Keen, Julie Skilbeck, Helen Ross, Lauren Smith, Joanne Dixey, Stephen J. Walters, Rebecca Simpson, Diana M. Greenfield, John A. Snowden
PHYSIOTHERAPY (2021)
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial
Beatrice Vergnano, Davide Signori, Annalisa Benini, Serena Calcinati, Francesca Bettini, Luisa Verga, Lorenza Maria Borin, Fabrizio Cavalca, Carlo Gambacorti-Passerini, Giacomo Bellani, Giuseppe Foti
JOURNAL OF CLINICAL MEDICINE (2023)
Efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice-weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study
Sosana Delimpasi, Maria Victoria Mateos, Holger W. Auner, Maria Gavriatopoulou, Meletios A. Dimopoulos, Hang Quach, Halyna Pylypenko, Roman Hajek, Xavier Leleu, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Reuben Benjamin, Mamta Krishnan Garg, Vadim Doronin, Yair Levy, Philippe Moreau, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Paul G. Richardson, Sebastian Grosicki
AMERICAN JOURNAL OF HEMATOLOGY (2022)
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant
Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, Thomas Drumel, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Benoit Tessoulin, Maxime Jullien, Sophie Vantyghem, Philippe Moreau, Steven Le Gouill, Marie C. Bene, Patrice Chevallier
BRITISH JOURNAL OF HAEMATOLOGY (2022)
All-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
Cyrille Touzeau, Aurore Perrot, Murielle Roussel, Lionel Karlin, Lotfi Benboubker, Caroline Jacquet, Mohamad Mohty, Thierry Facon, Salomon Manier, Marie-Lorraine Chretien, Mourad Tiab, Cyrille Hulin, Xavier Leleu, Herve Avet Loiseau, Thomas Dejoie, Lucie Planche, Michel Attal, Philippe Moreau
HAEMATOLOGICA (2022)
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis
Marcelo Capra, Thomas Martin, Philippe Moreau, Ross Baker, Ludek Pour, Chang-Ki Min, Xavier Leleu, Mohamad Mohty, Marta Reinoso Segura, Mehmet Turgut, Richard LeBlanc, Marie-Laure Risse, Laure Malinge, Sandrine Schwab, Meletios Dimopoulos
HAEMATOLOGICA (2022)
Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
Jean-Baptiste Alberge, Francoise Kraeber-Bodere, Bastien Jamet, Cyrille Touzeau, Helene Caillon, Soraya Wuilleme, Marie-Christine Bene, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Cherel, Philippe Moreau, Stephane Minvielle, Clement Bailly
JOURNAL OF NUCLEAR MEDICINE (2022)
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Paul G. Richardson, Aurore Perrot, Jesus San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A. Dimopoulos, Jeffrey Shang-Yi Huang, Jiri Minarik, Michele Cavo, H. Miles Prince, Laure Malinge, Franck Dubin, Helgi van de Velde, Kenneth C. Anderson
LANCET ONCOLOGY (2022)
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma
Arthur Bobin, Maeva Kyheng, Stephanie Guidez, Cecile Gruchet-Merouze, Valentine Richez, Alain Duhamel, Lionel Karlin, Brigitte Kolb, Mourad Tiab, Carla Araujo, Nathalie Meuleman, Jean-Valere Malfuson, Pascal Bourquard, Pascal Lenain, Aurore Perrot, Murielle Roussel, Arnaud Jaccard, Marie-Odile Petillon, Karim Belhadj-Merzoug, Marie-Lorraine Chretien, Jean Fontan, Philippe Rodon, Anna Schmitt, Fritz Offner, Laurent Voillat, Sophie Cereja, Frederique Kuhnowski, Sophie Rigaudeau, Olivier Decaux, Catherine Humbrecht-Kraut, Jamile Frayfer, Olivier Fitoussi, Damien Roos-Weil, Jean Claude Eisenmann, Veronique Dorvaux, Eric G. Voog, Philippe Moreau, Herve Avet-Loiseau, Cyrille Hulin, Thierry Facon, Xavier Leleu
LEUKEMIA (2022)
MRD in multiple myeloma: does CR really matter?
Bruno Paiva, Jesus San-Miguel, Herve Avet-Loiseau
BLOOD (2022)
T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?
Philippe Moreau, Cyrille Touzeau
BLOOD (2022)
Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
Saad Z. Usmani, Hareth Nahi, Wojciech Legiec, Sebastian Grosicki, Vladimir Vorobyev, Ivan Spicka, Vania Hungria, Sibirina Korenkova, Nizar J. Bahlis, Max Flogegard, Joan Blade, Philippe Moreau, Martin Kaiser, Shinsuke Iida, Jacob Laubach, Hila Magen, Michele Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, Kristen Lantz, Lisa O'Rourke, Christoph Heuck, Maria Delioukina, Xiang Qin, Ivo Nnane, Ming Qi, Maria-Victoria Mateos
HAEMATOLOGICA (2022)
The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM
Nicholas Stong, Maria Ortiz-Estevez, Fadi Towfic, Mehmet Samur, Amit Agarwal, Jill Corre, Erin Flynt, Nikhil Munshi, Herve Avet-Loiseau, Anjan Thakurta
BLOOD (2023)
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myelome study
Charles Dumontet, Delphine Demangel, Perrine Galia, Lionel Karlin, Laurent Roche, Mathieu Fauvernier, Camille Golfier, Marie-Charlotte Laude, Xavier Leleu, Philippe Rodon, Murielle Roussel, Isabelle Azais, Chantal Doyen, Borhane Slama, Salomon Manier, Olivier Decaux, Maroulio Pertesi, Marie Beaumont, Denis Caillot, Eileen M. Boyle, Manuel Cliquennois, Pascale Cony-Makhoul, Anne-Violaine Doncker, Veronique Dorvaux, Marie Odile Petillon, Jean Fontan, Benedicte Hivert, Isabelle Leduc, Cecile Leyronnas, Margaret Macro, Michel Maigre, Clara Mariette, Philippe Mineur, Sophie Rigaudeau, Bruno Royer, Laure Vincent, James Mckay, Emeline Perrial, Laurent Garderet
AMERICAN JOURNAL OF HEMATOLOGY (2023)
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
Giovanni Palladini, Stefan Schonland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios A. Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M. Teresa Cibeira, Hermine Agis, Monique C. Minnema, Rui Bergantim, Roman Hajek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh Wechalekar
BLOOD CANCER JOURNAL (2023)
Potential future direction of measurable residual disease evaluation in multiple myeloma
Mohamad Mohty, Herve Avet-Loiseau, Florent Malard, Jean-Luc Harousseau
BLOOD (2023)
Monoallelic deletion of BCMA is a frequent feature in multiple myeloma
Mehmet Kemal Samur, Anil Aktas Samur, Jill Corre, Romain Lannes, Parth Shah, Kenneth Anderson, Herve Avet-Loiseau, Nikhil Munshi
BLOOD ADVANCES (2023)